Taro Pharmaceutical Indus...

NYSE: TARO · Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Jun 21, 2024, 9:59 PM

Taro Pharmaceutical Industries Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
362.91M 154.5M 251.13M 605.18M
Short-Term Investments
516.44M 695.79M 569.61M 418.48M
Long-Term Investments
457.99M 404.9M 435.19M 557.21M
Other Long-Term Assets
82.45M 83.15M 6.77M 4.34M
Receivables
177.46M 241.8M 292.48M 252.86M
Inventory
204.82M 226.67M 210.44M 180.29M
Other Current Assets
41.77M 11.72M 14.22M 12.89M
Total Current Assets
1.3B 1.34B 1.34B 1.47B
Property-Plant & Equipment
217.59M 190.14M 199.69M 205.51M
Goodwill & Intangibles
17.23M 17.23M 71.94M 26.98M
Total Long-Term Assets
858.67M 799.09M 838.48M 936.04M
Total Assets
2.16B 2.14B 2.18B 2.41B
Account Payables
44.66M 68.48M 68.23M 61.17M
Deferred Revenue
n/a 903K 5.79M 7.58M
Short-Term Debt
n/a 1.95M 2.2M 1.69M
Other Current Liabilities
316.44M 314.21M 355.89M 605.86M
Total Current Liabilities
361.11M 385.55M 432.12M 676.3M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
7.96M -616K -919K -1.09M
Total Long-Term Liabilities
7.96M 19.11M 32.8M 35.12M
Total Liabilities
369.06M 404.65M 464.92M 711.42M
Total Debt
n/a 1.95M 2.2M 1.69M
Common Stock
1.79B 680K 680K 679K
Retained Earnings
n/a 2.41B 2.39B 2.34B
Comprehensive Income
n/a -175M -168.97M -151.62M
Shareholders Equity
1.79B 1.73B 1.71B 1.7B
Total Investments
974.43M 1.1B 1B 975.69M